Codebase Ventures updates on coronavirus trials of hydroxychloroquine, highlighting promising data

Credit: Proactive Investors- Published on May 11, 2020
Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF), which owns a 49% stake in a company developing a transdermal hydroxychloroquine (HCQ) patch, told investors Monday that five of seven completed clinical trials of the drug have shown favorable outcomes for coronavirus patients, although more data is necessary.  Hydroxychloroquine...
Advertisement

You are here


Related videos from verified sources

NY Dentists, Connecticut Hair Salons Allowed To Reopen 00:35
Credit: CBS 2 New York - Published on May 31, 2020 


Protest Crowds Cause Coronavirus Concerns 02:00
Credit: CBS 2 New York - Published on May 31, 2020 


DR Congo activists fight misinformation around COVID-19 02:10
Credit: Al Jazeera STUDIO - Published on May 31, 2020 


Related news from verified sources

Codebase Ventures Inc (CSE:CODE) (OTC:BKLLF) announced Wednesday that its investee Trad3r has launched a reimagined mobile game app and social media platform...
on May 13, 2020 • Proactive Investors

Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF) on Wednesday provided an update on its strategy toward the development of a transdermal delivery system for...
on May 20, 2020 • Proactive Investors

You might like